Sorry, but Notd.io is not available without javascript FDA backs Pfizer COVID-19 boosters for seniors, high-risk - notd.io

Read more about FDA backs Pfizer COVID-19 boosters for seniors, high-risk
Read more about FDA backs Pfizer COVID-19 boosters for seniors, high-risk
FDA backs Pfizer COVID-19 boosters for seniors, high-risk

By MATTHEW PERRONE, LAURAN NEERGAARD and MIKE STOBBE, Associated Press The U.S. moved a step closer Wednesday to offering booster doses of Pfizer’s COVID-19 vaccine to senior citizens and others at high risk from the virus as the Food and Drug Administration signed off on the targeted use of extra shots. The FDA authorized booster doses for Americans who are 65 and older, younger adults with underlying

You can publish here, too - it's easy and free.